📌 Raman spectroscopy is used for nondestructive monitoring of cell cultures, improving data collection during cultivation. 💡
📌 Streamlining upstream bioprocessing can reduce costs and facilitate the development of in silico digital twins. 🎯
📌 Smart experiments and hybrid modeling approaches can reduce the number of experiments needed by up to 70%. 🧪
📌 Leveraging artificial intelligence (AI) in bioprocessing can optimize and characterize processes and explore relationships between parameters. 🤖
📌 Next-generation bioreactors, such as Cytiva’s X-platform bioreactors, are designed for advanced cell culture processes. 🧫
Introduction:
This article discusses the use of nondestructive monitoring, in silico modeling, and optimized fluid dynamics in upstream bioprocessing to improve the production of biotherapeutics. The goal is to increase the efficiency and productivity of cell cultures and reduce costs, ultimately making biotherapeutics more accessible and affordable.
- Streamlining upstream process development and manufacturing through advanced modeling can reduce costs and facilitate the development of in silico digital twins.
- Instruments such as state-of-the-art bioreactors and Raman spectrophotometers can improve cell culture health and productivity and enable nondisruptive data collection.
- Hybrid modeling approaches combine machine learning with mechanistic knowledge to optimize upstream and downstream operations, reducing the number of experiments needed.
- Artificial intelligence (AI) approaches, such as Neuroevolution, can simulate cell growth and optimize and characterize processes, allowing for the exploration of relationships between different parameters.
- Next-generation bioreactors, such as Cytiva’s X-platform bioreactors, incorporate single-use technologies and optimized fluid dynamics to support demanding cell culture processes.
Conclusion:
The combination of nondestructive monitoring, in silico modeling, and optimized fluid dynamics offers great potential for improving upstream bioprocessing. These approaches can increase the efficiency of cell cultures, reduce costs, and improve the production of biotherapeutics. By leveraging advanced technologies and innovative workflows, researchers and manufacturers can accelerate the development of life-altering therapies and make them more accessible to patients in need.
